Optimizing Hamstring Rehabilitation With Amino Acids

NCT ID: NCT07086209

Last Updated: 2025-07-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-19

Study Completion Date

2025-10-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hamstring injuries are among the most prevalent and troublesome injuries in athletes, particularly those engaged in sports that require high-speed movements such as sprinting, kicking, and rapid changes in direction. The hamstring muscles, which include the biceps femoris, semitendinosus, and semimembranosus, are essential for powerful lower limb actions, and thus, any injury to these muscles can significantly impact an athlete's performance and recovery. These injuries often occur during eccentric muscle contractions, such as when the muscles lengthen rapidly under tension, as seen in running and sprinting. According to epidemiological studies, hamstring strains account for a substantial portion of sports-related injuries, with hamstring strains being the most commonly reported injury in disciplines such as football, soccer, rugby, and athletics. In professional football, for instance, hamstring injuries account for approximately 12% of all injuries and represent the most frequent muscle strain, underlining their significance in the context of athletic performance.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Seamless Return to Sports

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Therapeutic Exercise + Amino Acid Supplementation

Participants in this arm will undergo a structured 6-week therapeutic exercise rehabilitation program combined with daily oral branched-chain amino acid (BCAA) supplementation (10 g per day, divided into two doses: pre-training and post-training). The exercise program includes progressive isometric, eccentric, plyometric, and sprint-specific training to optimize hamstring recovery.

Group Type EXPERIMENTAL

Branched-Chain Amino Acid Supplement

Intervention Type DIETARY_SUPPLEMENT

Oral BCAA blend (leucine, isoleucine, valine), 10 g/day divided into two doses, pre- and post-training, for 6 weeks.

Therapeutic Exercise Program

Intervention Type BEHAVIORAL

6-week structured program including isometric, eccentric, plyometric, and sprint-specific exercises.

Therapeutic Exercise Only

Arm Description:

Participants in this arm will undergo the same structured 6-week therapeutic exercise rehabilitation program without any amino acid supplementation. The exercise program includes progressive isometric, eccentric, plyometric, and sprint-specific training for hamstring recovery.

Group Type ACTIVE_COMPARATOR

Branched-Chain Amino Acid Supplement

Intervention Type DIETARY_SUPPLEMENT

Oral BCAA blend (leucine, isoleucine, valine), 10 g/day divided into two doses, pre- and post-training, for 6 weeks.

Therapeutic Exercise Program

Intervention Type BEHAVIORAL

6-week structured program including isometric, eccentric, plyometric, and sprint-specific exercises.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Branched-Chain Amino Acid Supplement

Oral BCAA blend (leucine, isoleucine, valine), 10 g/day divided into two doses, pre- and post-training, for 6 weeks.

Intervention Type DIETARY_SUPPLEMENT

Therapeutic Exercise Program

6-week structured program including isometric, eccentric, plyometric, and sprint-specific exercises.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Therapeutic Exercise + Amino Acid Supplementation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Male football players aged 18 to 35 years.

* Active players from eight clubs in the Iraqi Football League.
* MRI-confirmed partial hamstring muscle injury.
* No participation in other ongoing rehabilitation programs.

Exclusion Criteria

* • History of hamstring injury in the past six months.

* Any other musculoskeletal injuries affecting lower limbs.
* Contraindications for MRI scanning (e.g., metal implants, pacemakers).
* Any existing neurological or metabolic conditions affecting muscle recovery.
Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad de Zaragoza

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kamal Hadib Abdulridha

PhD Student

Responsibility Role PRINCIPAL_INVESTIGATOR

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Unizar

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.